The American Academy of Pediatrics updated the guidelines for the management of hyperbilirubinemia in the newborn infants with a gestational age of ≥35 weeks in September 2022. Based on the evidence over the past 18 years, the guidelines are updated from the aspects of the prevention, risk assessment, intervention, and follow-up of hyperbilirubinemia in the newborn infants with a gestational age of ≥35 weeks. This article gives an interpretation of the key points in the guidelines, so as to safely reduce the risk of bilirubin encephalopathy and unnecessary intervention.
2022年9月美国儿科学会更新了胎龄≥35周新生儿高胆红素血症管理指南，该指南在整理总结过去18年循证证据的基础上，对胎龄≥35周新生儿高胆红素血症的预防、风险评估、干预及随访等内容进行了更新，现就核心要点进行解读，旨在安全地降低胆红素脑病的风险及不必要的干预风险。.
Keywords: Guideline; Hyperbilirubinemia; Interpretation; Newborn infant.